<DOC>
	<DOC>NCT01055691</DOC>
	<brief_summary>The primary objective of the study is to establish if the same amount of drug is absorbed into the blood after ingesting a combination dapagliflozin/metformin tablet vs. the individual dapagliflozin tablet and individual metformin tablet.</brief_summary>
	<brief_title>A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Female healthy volunteers must be postmenopausal (cessation of menses &gt;1year), be surgically sterile (documented) or hysterectomy or on abstinence Have normal physical exam, vital signs Electrocardiogram (ECG) findings, and laboratory values Use of prescription medication for a chronic or acute medical condition within 3 weeks of randomization History of allergy to metformin Previous participation in an AstraZeneca (AZ) or BristolMyersSqibb dapagliflozin study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>healthy volunteers</keyword>
	<keyword>bioequivalence</keyword>
	<keyword>dapagliflozin</keyword>
	<keyword>metformin</keyword>
</DOC>